Proposed Data Collections Submitted for Public Comment and Recommendations

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[INFO-96-20]

Proposed Data Collections Submitted for Public Comment and

Recommendations

In compliance with the requirement of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for opportunity for public comment on

proposed data collection projects, the Centers for Disease Control and

Prevention (CDC) will publish periodic summaries of proposed projects.

To request more information on the proposed projects or to obtain a

copy of the data collection plans and instruments, call the CDC Reports

Clearance Officer on (404) 639-7090.

Comments are invited on: (a) Whether the proposed collection of

information is necessary for the proper performance of the functions of

the agency, including whether the information shall have practical

utility; (b) the accuracy of the agency's estimate of the burden of the

proposed collection of information; (c) ways to enhance the quality,

utility, and clarity of the information to be collected; and (d) ways

to minimize the burden of the collection of information on respondents,

including through the use of automated collection techniques for other

forms of information technology. Send comments to Wilma Johnson, CDC

Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA

30333. Written comments should be received within 60 days of this

notice.

Proposed Projects

1. Reliability and Validity Assessment of the Use of Scales of

Stressful Life Events in Black Women of Reproductive Age--(0920-0356)--

Reinstatement--A CDC review of studies of psychosocial factors and

adverse pregnancy outcome supports the hypothesis that high levels of

exposure to stressful life experiences put black women at increased

risk for adverse reproductive outcome, particularly Preterm Delivery

(PTD) and Very Low Birth Weight (VLBW). The purpose of this study is to

evaluate the reliability and validity of existing instruments that

measure stressful life events in black women of reproductive age.

Respondents will consist of reproductive age residents who live in the

Atlanta area and who attend a health care facility that has a

behavioral prenatal unit. Approximately one half of the women will be

pregnant at the time of data collection.

Women enrolled in the study respond to a series of demographic and

psychosocial questionnaires. Women are also asked to provide a 24 hour

urine sample and saliva sample. Both samples are used to correlate

reported levels of stress with laboratory measures of stress.

Participation in this study is voluntary and participants will

receive a reimbursement for their time. A written informed consent will

be obtained and oversight will be provided by local institutional

review.

The study is ongoing and by December 31, 1996, approximately two-

thirds of data collection will be completed. In January 1997, we need

to continue data collection so that we will have 100 women for the

validity study and 29 women for the reliability study. To complete the

validity study, 100 women will be interviewed and will submit one 24

hour urine collection and a saliva sample. To complete the reliability

study, 29 women will be interviewed on two separate occasions to

determine whether responses to the structured stress scales are

consistent. These women will also submit a 24 hour urine collection and

a saliva sample. the total estimated cost to respondents is at $8,616.

----------------------------------------------------------------------------------------------------------------

No. of Avg. burden/

Respondents No. of responses/ response Total burden

respondents respondent (in hrs.) (in hrs.)

----------------------------------------------------------------------------------------------------------------

Reliability study group--African-American Women for the

ages of 18 to 45....................................... 29 1 13 377

Validity study group--African-American Women for the

ages of 18 to 45....................................... 100 1 7 700

-------------------------------------------------------

Total............................................... ............ ............ ............ 1,077

----------------------------------------------------------------------------------------------------------------

[[Page 40847]]

Dated: July 31, 1996.

Wilma G. Johnson,

Acting Associate Director for Policy Planning And Evaluation, Centers

for Disease Control and Prevention (CDC).

[FR Doc. 96-19935 Filed 8-5-96; 8:45 am]

BILLING CODE 4163-18-M